Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 130

3.

Thiazolidinediones inhibit growth of gastrointestinal, biliary, and pancreatic adenocarcinoma cells through activation of the peroxisome proliferator-activated receptor gamma/retinoid X receptor alpha pathway.

Tsujie M, Nakamori S, Okami J, Hayashi N, Hiraoka N, Nagano H, Dono K, Umeshita K, Sakon M, Monden M.

Exp Cell Res. 2003 Sep 10;289(1):143-51.

PMID:
12941612
4.

Peroxisome proliferator-activated receptor gamma ligand inhibits cell growth and invasion of human pancreatic cancer cells.

Hashimoto K, Ethridge RT, Evers BM.

Int J Gastrointest Cancer. 2002;32(1):7-22.

PMID:
12630765
5.

Involvement of p21(WAF1/Cip1), p27(Kip1), and p18(INK4c) in troglitazone-induced cell-cycle arrest in human hepatoma cell lines.

Koga H, Sakisaka S, Harada M, Takagi T, Hanada S, Taniguchi E, Kawaguchi T, Sasatomi K, Kimura R, Hashimoto O, Ueno T, Yano H, Kojiro M, Sata M.

Hepatology. 2001 May;33(5):1087-97.

PMID:
11343236
6.

PPARgamma ligand (thiazolidinedione) induces growth arrest and differentiation markers of human pancreatic cancer cells.

Elnemr A, Ohta T, Iwata K, Ninomia I, Fushida S, Nishimura G, Kitagawa H, Kayahara M, Yamamoto M, Terada T, Miwa K.

Int J Oncol. 2000 Dec;17(6):1157-64.

PMID:
11078801
7.

Peroxisome proliferator-activated receptor gamma ligands inhibit mitogenic induction of p21(Cip1) by modulating the protein kinase Cdelta pathway in vascular smooth muscle cells.

Wakino S, Kintscher U, Liu Z, Kim S, Yin F, Ohba M, Kuroki T, Schönthal AH, Hsueh WA, Law RE.

J Biol Chem. 2001 Dec 14;276(50):47650-7. Epub 2001 Oct 11.

8.

Activation of peroxisome proliferator-activated receptor-gamma stimulates the growth arrest and DNA-damage inducible 153 gene in non-small cell lung carcinoma cells.

Satoh T, Toyoda M, Hoshino H, Monden T, Yamada M, Shimizu H, Miyamoto K, Mori M.

Oncogene. 2002 Mar 28;21(14):2171-80. Erratum in: Oncogene 2002 Nov 21;21(53):8220. Yamada, Masanabu [corrected to Yamada, Masanobu]; Mori, Matsumoto [corrected to Mori, Masatomo].

9.

Ligands for peroxisome proliferator-activated receptor gamma inhibit growth of pancreatic cancers both in vitro and in vivo.

Itami A, Watanabe G, Shimada Y, Hashimoto Y, Kawamura J, Kato M, Hosotani R, Imamura M.

Int J Cancer. 2001 Nov 1;94(3):370-6.

10.
11.

Peroxisome proliferator-activated receptor-gamma upregulates caveolin-1 and caveolin-2 expression in human carcinoma cells.

Burgermeister E, Tencer L, Liscovitch M.

Oncogene. 2003 Jun 19;22(25):3888-900.

PMID:
12813462
12.

Induction of E-cadherin in lung cancer and interaction with growth suppression by histone deacetylase inhibition.

Kakihana M, Ohira T, Chan D, Webster RB, Kato H, Drabkin HA, Gemmill RM.

J Thorac Oncol. 2009 Dec;4(12):1455-65. doi: 10.1097/JTO.0b013e3181bc9419.

13.

Peroxisome proliferator-activated receptor gamma and transforming growth factor-beta pathways inhibit intestinal epithelial cell growth by regulating levels of TSC-22.

Gupta RA, Sarraf P, Brockman JA, Shappell SB, Raftery LA, Willson TM, DuBois RN.

J Biol Chem. 2003 Feb 28;278(9):7431-8. Epub 2002 Dec 4.

14.

Histone acetylation may suppress human glioma cell proliferation when p21 WAF/Cip1 and gelsolin are induced.

Kamitani H, Taniura S, Watanabe K, Sakamoto M, Watanabe T, Eling T.

Neuro Oncol. 2002 Apr;4(2):95-101.

17.
18.

Histone deacetylase inhibitor enhances sensitivity of non-small-cell lung cancer cells to 5-FU/S-1 via down-regulation of thymidylate synthase expression and up-regulation of p21(waf1/cip1) expression.

Noro R, Miyanaga A, Minegishi Y, Okano T, Seike M, Soeno C, Kataoka K, Matsuda K, Yoshimura A, Gemma A.

Cancer Sci. 2010 Jun;101(6):1424-30. doi: 10.1111/j.1349-7006.2010.01559.x. Epub 2010 Mar 10.

19.

Histone deacetylase inhibitors radiosensitize human melanoma cells by suppressing DNA repair activity.

Munshi A, Kurland JF, Nishikawa T, Tanaka T, Hobbs ML, Tucker SL, Ismail S, Stevens C, Meyn RE.

Clin Cancer Res. 2005 Jul 1;11(13):4912-22.

20.

Histone deacetylase inhibitors activate INK4d gene through Sp1 site in its promoter.

Yokota T, Matsuzaki Y, Miyazawa K, Zindy F, Roussel MF, Sakai T.

Oncogene. 2004 Jul 8;23(31):5340-9.

PMID:
15107822

Supplemental Content

Support Center